Answer
Yes, under the law, the first prescription or renewed prescription of a medicinal cannabis product from 1 August 2022 must be reported as a professional duty. This applies both for a first-time prescription after the revision of the Act on 1 August 2022 and also for treatment already in progress. Follow-up reports are then only required after one year and after two years of treatment.